首頁 > 市場調查報告書 > 醫療設備

運輸/物流生技設備

市場調查報告書

商品編碼

1737087

全球醫療物流市場規模（按服務、產品類型、區域覆蓋範圍和預測）

Global Healthcare Logistics Market Size By Service (Pharmaceutical Products, Medical Devices), By Product Type (Transportation, Warehousing), By Geographic Scope And Forecast

出版日期: 2025年05月08日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

醫療保健物流市場規模與預測

2024 年醫療物流市場規模價值為 848.8 億美元，預計到 2032 年將達到 1,793.1 億美元，2026 年至 2032 年的複合年成長率為 9.68%。

醫療物流是一個複雜的系統，需要規劃、管理和協調醫療物資、設備、藥品、器官、組織甚至人員在正確的時間和地點條件下的運輸。醫療物流與傳統物流的不同之處在於，它處理的是生命攸關的產品，需要專門的處理和精準的交付時間。

這個專業領域可分為三個階段：第一英里、中間英里和最後一英里。第一英里是將藥品從製造商運送到分銷點。中間英里專注於將這些貨物運送到醫院、診所和藥房。最後一哩路確保藥品和設備在需要時直接送達患者手中。

高效的醫療物流對於確保病患的安全和健康至關重要。它確保醫院和診所擁有足夠的物資，有效地治療患者。及時送達藥品，尤其是重症加護所需的藥品，可能關乎生死。此外，對溫度敏感的藥品和疫苗必須妥善儲存和運輸，以保持其有效性。

醫療物流不僅對這些基本職能至關重要，對研發也至關重要。它促進了臨床試驗材料和生物樣本的運輸，加速了醫學進步。此外，強大的物流系統對於血庫、器官捐贈計畫和緊急應變措施也至關重要。

全球醫療保健物流市場動態

影響全球醫療物流市場的關鍵市場動態是：

關鍵市場促進因素

藥品和醫療設備需求不斷成長：全球藥品和醫療設備市場的成長受到多種因素的推動。人口老化、醫療保健需求的不斷成長以及慢性病的增多，推動了對藥物和現代醫療設備的需求。此外，醫學研發的進步也帶來了新藥和新技術的推出，推動了市場擴張。

技術進步：人工智慧 (AI)、區塊鏈和物聯網 (IoT) 等新興技術的結合正在改變醫療物流。人工智慧解決方案可以改善庫存管理，預測需求波動，並簡化配送路線。區塊鏈技術正在提高整個供應鏈的透明度和可追溯性，確保產品真實性並減少假冒產品。

注重成本效益和業務最佳化：醫療保健提供者和製藥公司面臨著在保持卓越服務水平的同時降低成本的壓力。最佳化物流營運可以透過改善庫存管理、減少浪費和提供高效的運輸方案來降低成本。

策略夥伴關係與合作：物流和醫療保健公司擴大建立策略夥伴關係或聯盟，利用第三方供應商的物流經驗，使供應鏈更具彈性、更有效率、應對力市場。

主要問題

確保產品完整性並維持低溫運輸控制：醫療物流市場很大一部分涉及對溫度敏感的產品，例如疫苗、血液製品、藥品和生物樣本。即使是輕微的溫度波動也可能影響這些藥物的功效和效用，並可能對患者健康造成不利影響。在整個供應鏈中（從製造到照護現場交付）保持穩定理想的溫度仍然是一項重大挑戰。

資料安全和隱私問題：醫療保健物流涉及處理敏感的病患數據，包括藥品、醫療記錄和保險資訊。網路安全威脅一直是該行業的焦點，資料外洩可能造成嚴重後果。投資強大的網路安全保障措施、為員工提供資料保護程序培訓以及遵守嚴格的資料隱私法，對於保護敏感資訊至關重要。

應對「最後一公里」挑戰：「最後一公里」——將醫療物資直接送達患者家中或護理機構——對醫療物流供應商構成了獨特的挑戰。地域分散、道路擁擠以及病患需求的多樣化都會對配送時間和成本產生重大影響。開發創造性的「最後一公里」配送替代方案，例如使用無人機或與本地配送供應商合作，有助於克服這些問題。

勞動力短缺和營運成本上升：與許多其他企業一樣，醫療物流企業也面臨嚴重的人手不足。很難找到具備處理精密醫療產品所需經驗的合格人員。這種人手不足可能導致供應鏈出現延誤、效率低落和錯誤。

主要趨勢

技術整合：物聯網 (IoT)、區塊鏈和人工智慧 (AI) 等先進技術正在醫療物流迅速應用，以提高供應鏈的效率、透明度和安全性。這些技術能夠即時追蹤藥品和醫療設備，從而改善庫存管理並降低仿冒品的風險。

低溫運輸物流：隨著對生物製藥和疫苗等溫度敏感醫療產品的需求不斷增加，對先進的低溫運輸低溫運輸物流物流的需求也在不斷增加——配備溫度監控系統的專用儲存和運輸設施，以確保從製造到分銷的精密醫療產品的安全。

法規合規與品質保證：嚴格的法規，尤其是在醫藥物流，持續推動對合規和品質保證程序的投資。企業正在投資先進的追蹤技術，以確保符合《藥品分銷規範》(GDP) 和《藥品供應鏈安全法》等要求。

致力於永續性：環境永續性已成為醫療物流供應商的首要任務。他們越來越重視減少碳排放、消除廢棄物並最佳化整個供應鏈的資源利用。相關措施包括使用環保包裝材料、節能運輸和回收計劃。

概述
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 其他亞太地區
拉丁美洲
- 巴西
- 阿根廷
- 其他拉丁美洲
中東和非洲
- 阿拉伯聯合大公國
- 沙烏地阿拉伯
- 南非
- 其他中東和非洲地區

第8章全球醫療物流市場的競爭格局

概述
各公司市場排名
公司地理分佈
公司在各行業的足跡
ACE矩陣

第9章公司簡介

Deutsche Post DHL
Kuehne+Nagel
UPS（Marken）
DB Group
FedEx
Air Canada
AmerisourceBergen Corp.
CEVA Logistics AG
Continental Cargo OU
United Parcel Service Inc
Emerald Freight Express
Cavalier Logistics Management II, Inc.
Alloga
KERRY LOGISTICS NETWORK LIMITED
NIPPON EXPRESS CO., LTD.
Propeller Health
Cohero Health Inc.
GlaxoSmithKline
AstraZeneca plc
Novartis AG
3M Company
Teva Pharmaceuticals
Vectura Group
Cognita Labs, Llc

第 11 章已驗證的市場情報

關於已驗證的市場情報
動態資料視覺化

簡介目錄

Product Code: 50205

Healthcare Logistics Market Size And Forecast

Healthcare Logistics Market size was valued at USD 84.88 Billion in 2024 and is projected to reach USD 179.31 Billion by 2032, growing at a CAGR of 9.68% from 2026 to 2032.

Healthcare logistics is a complicated system of planning, managing, and coordinating the movement of medical supplies, equipment, medications, organs, tissues, and even individuals to the appropriate location, time, and condition. Healthcare logistics, unlike conventional logistics, deals with life-critical products that necessitate particular handling and exact delivery times.

This particular field can be divided into three stages: the first mile, the middle mile, and the final mile. The first mile entails transporting medicinal items from manufacturers to distribution sites. The middle mile focuses on delivering these goods to hospitals, clinics, and pharmacies. Finally, the last mile guarantees that medications and equipment are delivered directly to patients, as needed.

Efficient healthcare logistics are critical to guaranteeing patient safety and well-being. It ensures that hospitals and clinics have enough supplies to treat patients efficiently. The timely delivery of medications, particularly those required for critical care, might be the difference between life and death. Additionally, temperature-sensitive medications and vaccines must be stored and transported properly to maintain their potency.

Beyond these essential functions, healthcare logistics is critical for research and development. It makes it easier to move clinical trial materials and biological samples, which speeds up medical advances. Furthermore, robust logistical systems are vital for handling blood banks, organ donation programs, and emergency response measures.

Global Healthcare Logistics Market Dynamics

The key market dynamics that are shaping the global healthcare logistics market include:

Key Market Drivers:

Rising Demand for Pharmaceuticals and Medical Devices: Several factors contribute to the globally pharmaceutical and medical device sectors' growth. An aging population with increasing healthcare needs, combined with the rise in chronic diseases, is driving up demand for drugs and modern medical equipment. Furthermore, advances in medical research & development are resulting in the introduction of novel medications and technologies, which is driving market expansion.

Technological Advancements: The combination of advanced technologies such as artificial intelligence (AI), blockchain, and the Internet of Things (IoT) is transforming healthcare logistics. Artificial intelligence-powered solutions can improve inventory management, forecast demand variations, and streamline delivery routes. Blockchain technology improves transparency and traceability throughout the supply chain, ensuring product authenticity and reducing counterfeiting.

Focus on Cost Efficiency and Operational Optimization: Healthcare providers and pharmaceutical companies face pressure to save costs while maintaining excellent service levels. Optimizing logistics operations saves money by improving inventory management, reducing waste, and providing effective transportation options.

Strategic Partnerships and Collaborations: Logistics and healthcare firms are increasingly forming strategic partnerships and collaborations. These alliances use third-party suppliers' logistical experience to increase supply chain resilience, efficiency, and market response.

Key Challenges:

Ensure Product Integrity and Maintain Cold Chain Management: A substantial percentage of the healthcare logistics market is concerned with temperature-sensitive products such as vaccines, blood products, medications, and biological samples. Even modest temperature fluctuations can have an impact on the effectiveness and usefulness of these medications, potentially causing negative health repercussions for patients. Maintaining a stable and ideal temperature across the supply chain, from manufacture to point-of-care delivery, is still a substantial challenges.

Data Security and Privacy Concerns: Healthcare logistics entails dealing with sensitive patient data such as medicines, medical records, and insurance information. Cybersecurity threats are an ongoing worry for the sector, and data breaches can have disastrous effects. Investing in strong cybersecurity safeguards, providing employee training on data protection procedures, and adhering to tight data privacy legislation is essential for protecting sensitive information.

Managing the "Last Mile" Challenge: The "last mile," or delivering medical supplies directly to patients' homes or care facilities, provides a unique set of obstacles for healthcare logistics providers. Geographic dispersion, road congestion, and diverse patient needs all have a substantial impact on delivery times and costs. Developing creative last-mile delivery alternatives, such as using drones or cooperating with local delivery firms, can help to overcome these issues.

Labor Shortages and Rising Operational Costs: The healthcare logistics business, like many others, is experiencing a serious manpower shortage. Finding qualified individuals with the necessary experience to handle delicate medical items might be difficult. This scarcity may cause delays, inefficiencies, and errors in the supply chain.

Key Trends:

Technology Integration: Advanced technologies such as the Internet of Things (IoT), blockchain, and artificial intelligence (AI) are rapidly being used in healthcare logistics to improve supply chain efficiency, transparency, and security. These technologies offer real-time tracking of pharmaceuticals and medical devices, resulting in improved inventory management and a reduced risk of counterfeit products.

Cold Chain Logistics: As the need for temperature-sensitive medical products such as biopharmaceuticals and vaccines grows, so does the need for advanced cold chain logistics solutions. This comprises specialized storage and transportation facilities outfitted with temperature-monitoring systems to ensure the safety of sensitive healthcare products from manufacturing to delivery.

Regulatory Compliance and Quality Assurance: Stringent regulatory regulations, particularly in pharmaceutical logistics, continue to motivate investments in compliance and quality assurance procedures. Companies are investing in advanced tracking and tracing technologies to ensure compliance with requirements such as Good Distribution Practices (GDP) and the Drug Supply Chain Security Act.

Sustainability Initiatives: Environmental sustainability has become a top priority for healthcare logistics providers. Throughout the supply chain, there is an increasing emphasis on lowering carbon emissions, eliminating waste, and optimizing resource use. Initiatives include the use of environmentally friendly packaging materials, energy-efficient modes of transportation, and recycling programs.

Global Healthcare Logistics Market Regional Analysis

Here is a more detailed regional analysis of the global healthcare logistics market:

North America:

North America is the largest global healthcare logistics market shareholder and is expected to grow at a CAGR of 7.75% over the forecast period. As the region's senior population grows, so does the incidence of chronic diseases, creating a demand for modern healthcare products and services, as well as improved medical help, to effectively treat the growing number of chronic disease patients.

As a result, there is a higher demand in this region for safe and secure transportation of drugs, medical equipment, and devices. According to a 2017 WTO assessment, the United States is the world's second-largest exporter of medical products, with reported exports totaling USD 116 billion.

The United States is also the world's second-largest ventilator exporter and third-largest exporter of personal protection equipment. The high tolerance and open-mindedness of North American citizens has supported healthcare institutions in creating and implementing an abundance of novel healthcare supply chain technology.

Europe:

Europe is expected to have a CAGR of 7.33% throughout the projection period. Current healthcare operations in Europe include value-based care, cost and margin issues, and increasing regulatory and compliance requirements.

These factors encourage healthcare manufacturers to adjust their supply chain operations in order to remain competitive in the logistics market and continue to assist healthcare providers by prioritizing patients.

Within the European medical device sector, there are two primary markets: mature (Western Europe) and emerging (East Europe). To meet Europe's demand for medical devices and pharmaceuticals, producers and logistics providers must supply low-cost logistical services.

Because of the gravity of the COVID situation, the European healthcare industry is working around the clock to assure a steady supply of necessary pharmaceuticals, medical supplies, and protective equipment. These rules have an immediate and severe influence on internationally connected supply chains, which drives regional market expansion.

Global Healthcare Logistics Market: Segmentation Analysis

The Global Healthcare Logistics Market is Segmented on the basis of Service, and Product Type And Geography.

Healthcare Logistics Market, By Service

Pharmaceutical Products
Medical Devices

Based on Service, the market is bifurcated into Pharmaceutical Products, and Medical Devices. The pharmaceutical products segment is currently dominating the Healthcare Logistics Market. It is expected to have the largest share throughout the forecast period due to the huge volume and value of pharmaceuticals shipped internationally. However, the medical device market is expected to be the fastest-growing segment. This expansion is linked to rising demand for complicated medical devices and increased use of minimally invasive procedures.

Healthcare Logistics Market, By Product Type

Transportation
Warehousing

Based on Product Type, the market is fragmented into Transportation and Warehousing. Transportation is currently the most dominant segment. This is due to the vital transportation of medical supplies, drugs, and equipment that must be delivered on time and often saves lives. Efficient transportation ensures that these products reach healthcare professionals rapidly. Warehousing is the fastest-growing segment. This growth is being driven by the increased use of complicated biological medications and the growing necessity for temperature-controlled storage. Warehousing businesses are creating specialized facilities to suit these rigorous standards.

Healthcare Logistics Market, By Geography

North America
Europe
Asia Pacific
Rest of the World
On the basis of Geography, the Global Healthcare Logistics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America currently dominates the market due to its strong pharmaceutical and biopharmaceutical sectors and high healthcare spending. They maintain a consistent growth rate. Europe has a sizable stake, with an emphasis on innovative technologies and regulations. Growth is likely to remain constant.

Key Players

The "Global Healthcare Logistics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Deutsche Post DHL, Kuehne + Nagel, UPS (Marken), DB Group, FedEx, Air Canada, AmerisourceBergen Corp., CEVA Logistics AG, Continental Cargo OU, United Parcel Service Inc, Emerald Freight Express, Cavalier Logistics Management II, Inc., Alloga, KERRY LOGISTICS NETWORK LIMITED, and NIPPON EXPRESS CO., LTD., Adherium, Propeller Health, Cohero Health Inc., GlaxoSmithKline, AstraZeneca plc, Novartis AG, 3M Company, Teva Pharmaceuticals, Vectura Group, Cognita Labs, Llc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Healthcare Logistics Market Recent Developments
In November 2022, Cardinal Health announced the debut of VelocareTM, a supply chain network and last-mile fulfillment solution capable of delivering necessary materials and services required for hospital-level care to patients' homes in one to two hours.
In August 2022, United Parcel Service Inc announced that it will buy Bomi Group, an Italian healthcare logistics company, to improve its ability to transport drugs that require cold storage.

1 INTRODUCTION OF GLOBAL HEALTHCARE LOGISTICS MARKET

1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Assumptions
1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

2.1 Data Mining
2.2 Data Triangulation
2.3 Bottom-Up Approach
2.4 Top-Down Approach
2.5 Research Flow
2.6 Key Insights from Industry Experts
2.7 Data Sources

3 EXECUTIVE SUMMARY

3.1 Market Overview
3.2 Ecology Mapping
3.3 Absolute Market Opportunity
3.4 Market Attractiveness
3.5 Global Healthcare Logistics Market Geographical Analysis (CAGR %)
3.6 Global Healthcare Logistics Market, By Product Type (USD Million)
3.7 Global Healthcare Logistics Market, By Service (USD Million)
3.8 Future Market Opportunities
3.9 Global Market Split
3.10 Product Life Line

4 GLOBAL HEALTHCARE LOGISTICS MARKET OUTLOOK

4.1 Global Healthcare Logistics Evolution
4.2 Drivers
- 4.2.1 Driver1
- 4.2.2 Driver 2
4.3 Restraints
- 4.3.1 Restraint1
- 4.3.2 Restraint 2
4.4 Opportunities
- 4.4.1 Opportunity1
- 4.4.2 Opportunity 2
4.5 Porters Five Force Model
4.6 Value Chain Analysis
4.7 Pricing Analysis
4.8 Macroeconomic Analysis

5 GLOBAL HEALTHCARE LOGISTICS MARKET, BY PRODUCT TYPE

5.1 Overview
5.2 Transportation
5.3 Warehousing

6 GLOBAL HEALTHCARE LOGISTICS MARKET, BY SERVICE

6.1 Overview
6.2 Pharmaceutical Products
6.3 Medical devices

7 GLOBAL HEALTHCARE LOGISTICS MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Argentina
- 7.5.3 Rest of Latin America
7.6 Middle-East and Africa
- 7.6.1 UAE
- 7.6.2 Saudi Arabia
- 7.6.3 South Africa
- 7.6.4 Rest of Middle-East and Africa

8 GLOBAL HEALTHCARE LOGISTICS MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Developments
8.4 Company Regional Footprint
8.5 Company Industry Footprint
8.6 ACE Matrix

9 COMPANY PROFILES

9.1 Deutsche Post DHL
- 9.1.1 Company Overview
- 9.1.2 Company Insights
- 9.1.3 Product Benchmarking
- 9.1.4 Key Development
- 9.1.5 Winning Imperatives
- 9.1.6 Current Focus & Strategies
- 9.1.7 Threat from Competition
- 9.1.8 SWOT Analysis
9.2 Kuehne + Nagel
- 9.2.1 Company Overview
- 9.2.2 Company Insights
- 9.2.3 Product Benchmarking
- 9.2.4 Key Development
- 9.2.5 Winning Imperatives
- 9.2.6 Current Focus & Strategies
- 9.2.7 Threat from Competition
- 9.2.8 SWOT Analysis
9.3 UPS (Marken)
- 9.3.1 Company Overview
- 9.3.2 Company Insights
- 9.3.3 Product Benchmarking
- 9.3.4 Key Development
- 9.3.5 Winning Imperatives
- 9.3.6 Current Focus & Strategies
- 9.3.7 Threat from Competition
- 9.3.8 SWOT Analysis
9.4 DB Group
- 9.4.1 Company Overview
- 9.4.2 Company Insights
- 9.4.3 Product Benchmarking
- 9.4.4 Key Development
- 9.4.5 Winning Imperatives
- 9.4.6 Current Focus & Strategies
- 9.4.7 Threat from Competition
- 9.4.8 SWOT Analysis
9.5 FedEx
- 9.5.1 Company Overview
- 9.5.2 Company Insights
- 9.5.3 Product Benchmarking
- 9.5.4 Key Development
- 9.5.5 Winning Imperatives
- 9.5.6 Current Focus & Strategies
- 9.5.7 Threat from Competition
- 9.5.8 SWOT Analysis
9.6 Air Canada
- 9.6.1 Company Overview
- 9.6.2 Company Insights
- 9.6.3 Product Benchmarking
- 9.6.4 Key Development
- 9.6.5 Winning Imperatives
- 9.6.6 Current Focus & Strategies
- 9.6.7 Threat from Competition
- 9.6.8 SWOT Analysis
9.7 AmerisourceBergen Corp.
- 9.7.1 Company Overview
- 9.7.2 Company Insights
- 9.7.3 Product Benchmarking
- 9.7.4 Key Development
- 9.7.5 Winning Imperatives
- 9.7.6 Current Focus & Strategies
- 9.7.7 Threat from Competition
- 9.7.8 SWOT Analysis
9.8 CEVA Logistics AG
- 9.8.1 Company Overview
- 9.8.2 Company Insights
- 9.8.3 Product Benchmarking
- 9.8.4 Key Development
- 9.8.5 Winning Imperatives
- 9.8.6 Current Focus & Strategies
- 9.8.7 Threat from Competition
- 9.8.8 SWOT Analysis
9.9 Continental Cargo OU
- 9.9.1 Company Overview
- 9.9.2 Company Insights
- 9.9.3 Product Benchmarking
- 9.9.4 Key Development
- 9.9.5 Winning Imperatives
- 9.9.6 Current Focus & Strategies
- 9.9.7 Threat from Competition
- 9.9.8 SWOT Analysis
9.10 United Parcel Service Inc
- 9.10.1 Company Overview
- 9.10.2 Company Insights
- 9.10.3 Product Benchmarking
- 9.10.4 Key Development
- 9.10.5 Winning Imperatives
- 9.10.6 Current Focus & Strategies
- 9.10.7 Threat from Competition
- 9.10.8 SWOT Analysis
9.11 Emerald Freight Express
- 9.11.1 Company Overview
- 9.11.2 Company Insights
- 9.11.3 Product Benchmarking
- 9.11.4 Key Development
- 9.11.5 Winning Imperatives
- 9.11.6 Current Focus & Strategies
- 9.11.7 Threat from Competition
- 9.11.8 SWOT Analysis
9.12 Cavalier Logistics Management II, Inc.
- 9.12.1 Company Overview
- 9.12.2 Company Insights
- 9.12.3 Product Benchmarking
- 9.12.4 Key Development
- 9.12.5 Winning Imperatives
- 9.12.6 Current Focus & Strategies
- 9.12.7 Threat from Competition
- 9.12.8 SWOT Analysis
9.13 Alloga
- 9.13.1 Company Overview
- 9.13.2 Company Insights
- 9.13.3 Product Benchmarking
- 9.13.4 Key Development
- 9.13.5 Winning Imperatives
- 9.13.6 Current Focus & Strategies
- 9.13.7 Threat from Competition
- 9.13.8 SWOT Analysis
9.14 KERRY LOGISTICS NETWORK LIMITED
- 9.14.1 Company Overview
- 9.14.2 Company Insights
- 9.14.3 Product Benchmarking
- 9.14.4 Key Development
- 9.14.5 Winning Imperatives
- 9.14.6 Current Focus & Strategies
- 9.14.7 Threat from Competition
- 9.14.8 SWOT Analysis
9.15 NIPPON EXPRESS CO., LTD.
- 9.15.1 Company Overview
- 9.15.2 Company Insights
- 9.15.3 Product Benchmarking
- 9.15.4 Key Development
- 9.15.5 Winning Imperatives
- 9.15.6 Current Focus & Strategies
- 9.15.7 Threat from Competition
- 9.15.8 SWOT Analysis
9.16 Propeller Health
- 9.16.1 Company Overview
- 9.16.2 Company Insights
- 9.16.3 Product Benchmarking
- 9.16.4 Key Development
- 9.16.5 Winning Imperatives
- 9.16.6 Current Focus & Strategies
- 9.16.7 Threat from Competition
- 9.16.8 SWOT Analysis
9.17 Cohero Health Inc.
- 9.17.1 Company Overview
- 9.17.2 Company Insights
- 9.17.3 Product Benchmarking
- 9.17.4 Key Development
- 9.17.5 Winning Imperatives
- 9.17.6 Current Focus & Strategies
- 9.17.7 Threat from Competition
- 9.17.8 SWOT Analysis
9.18 GlaxoSmithKline
- 9.18.1 Company Overview
- 9.18.2 Company Insights
- 9.18.3 Product Benchmarking
- 9.18.4 Key Development
- 9.18.5 Winning Imperatives
- 9.18.6 Current Focus & Strategies
- 9.18.7 Threat from Competition
- 9.18.8 SWOT Analysis
9.19 AstraZeneca plc
- 9.19.1 Company Overview
- 9.19.2 Company Insights
- 9.19.3 Product Benchmarking
- 9.19.4 Key Development
- 9.19.5 Winning Imperatives
- 9.19.6 Current Focus & Strategies
- 9.19.7 Threat from Competition
- 9.19.8 SWOT Analysis
9.20 Novartis AG
- 9.20.1 Company Overview
- 9.20.2 Company Insights
- 9.20.3 Product Benchmarking
- 9.20.4 Key Development
- 9.20.5 Winning Imperatives
- 9.20.6 Current Focus & Strategies
- 9.20.7 Threat from Competition
- 9.20.8 SWOT Analysis
9.21 3M Company
- 9.21.1 Company Overview
- 9.21.2 Company Insights
- 9.21.3 Product Benchmarking
- 9.21.4 Key Development
- 9.21.5 Winning Imperatives
- 9.21.6 Current Focus & Strategies
- 9.21.7 Threat from Competition
- 9.21.8 SWOT Analysis
9.22 Teva Pharmaceuticals
- 9.22.1 Company Overview
- 9.22.2 Company Insights
- 9.22.3 Product Benchmarking
- 9.22.4 Key Development
- 9.22.5 Winning Imperatives
- 9.22.6 Current Focus & Strategies
- 9.22.7 Threat from Competition
- 9.22.8 SWOT Analysis
9.23 Vectura Group
- 9.23.1 Company Overview
- 9.23.2 Company Insights
- 9.23.3 Product Benchmarking
- 9.23.4 Key Development
- 9.23.5 Winning Imperatives
- 9.23.6 Current Focus & Strategies
- 9.23.7 Threat from Competition
- 9.23.8 SWOT Analysis
9.24 Cognita Labs, Llc
- 9.24.1 Company Overview
- 9.24.2 Company Insights
- 9.24.3 Product Benchmarking
- 9.24.4 Key Development
- 9.24.5 Winning Imperatives
- 9.24.6 Current Focus & Strategies
- 9.24.7 Threat from Competition
- 9.24.8 SWOT Analysis